Cargando…
Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation
Digoxin is used for rate control in atrial fibrillation (AF), but evidence for its efficacy and safety after myocardial infarction (MI) is scarce and mixed. We studied post‐MI digoxin use effects on AF patient outcomes in a nationwide registry follow‐up study in Finland. Digoxin was used by 18.6% of...
Autores principales: | Kytö, Ville, Saraste, Antti, Rautava, Päivi, Tornio, Aleksi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321089/ https://www.ncbi.nlm.nih.gov/pubmed/35420260 http://dx.doi.org/10.1111/bcpt.13733 |
Ejemplares similares
-
Initial statin dose after myocardial infarction and long-term cardiovascular outcomes
por: Kytö, Ville, et al.
Publicado: (2022) -
Lack of Statin Therapy and Outcomes After Ischemic Stroke: A Population-Based Study
por: Åivo, Julia, et al.
Publicado: (2023) -
Sex Differences in Cardiovascular Outcomes of Older Adults After Myocardial Infarction
por: Kerola, Anne M., et al.
Publicado: (2021) -
Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study
por: Palomäki, Antti, et al.
Publicado: (2021) -
Likelihood and Predictors of ST-Elevation in Patients Hospitalized for Myocardial Infarction
por: Kytö, Ville, et al.
Publicado: (2014)